CL2014003247A1 - Vacuna subunitaria, polivalente contra mastitis en mamíferos, que comprende fragmentos de pared y membrana celular de patógenos seleccionados de staphylococcus aureus, escherichia coli y streptococcus uberis; procedimiento de preparación; y uso para inmunogenizar un mamífero. - Google Patents

Vacuna subunitaria, polivalente contra mastitis en mamíferos, que comprende fragmentos de pared y membrana celular de patógenos seleccionados de staphylococcus aureus, escherichia coli y streptococcus uberis; procedimiento de preparación; y uso para inmunogenizar un mamífero.

Info

Publication number
CL2014003247A1
CL2014003247A1 CL2014003247A CL2014003247A CL2014003247A1 CL 2014003247 A1 CL2014003247 A1 CL 2014003247A1 CL 2014003247 A CL2014003247 A CL 2014003247A CL 2014003247 A CL2014003247 A CL 2014003247A CL 2014003247 A1 CL2014003247 A1 CL 2014003247A1
Authority
CL
Chile
Prior art keywords
immunogenize
mammals
mammal
escherichia coli
cell wall
Prior art date
Application number
CL2014003247A
Other languages
English (en)
Inventor
Acevedo Lisette Nicole Lapierre
Iturriaga Leonardo Enrique Sáenz
Original Assignee
Univ Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chile filed Critical Univ Chile
Priority to CL2014003247A priority Critical patent/CL2014003247A1/es
Publication of CL2014003247A1 publication Critical patent/CL2014003247A1/es
Priority to BR112017011292-2A priority patent/BR112017011292B1/pt
Priority to PCT/CL2015/050046 priority patent/WO2016082054A1/es
Priority to MX2017006892A priority patent/MX2017006892A/es
Priority to CONC2017/0005389A priority patent/CO2017005389A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2014003247A 2014-11-28 2014-11-28 Vacuna subunitaria, polivalente contra mastitis en mamíferos, que comprende fragmentos de pared y membrana celular de patógenos seleccionados de staphylococcus aureus, escherichia coli y streptococcus uberis; procedimiento de preparación; y uso para inmunogenizar un mamífero. CL2014003247A1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CL2014003247A CL2014003247A1 (es) 2014-11-28 2014-11-28 Vacuna subunitaria, polivalente contra mastitis en mamíferos, que comprende fragmentos de pared y membrana celular de patógenos seleccionados de staphylococcus aureus, escherichia coli y streptococcus uberis; procedimiento de preparación; y uso para inmunogenizar un mamífero.
BR112017011292-2A BR112017011292B1 (pt) 2014-11-28 2015-11-25 Vacina subunidade, polivalente, altamente imunogênica contra a mastite em mamíferos, processo para a preparação da dita vacina e usos da mesma
PCT/CL2015/050046 WO2016082054A1 (es) 2014-11-28 2015-11-25 Vacuna subunitaria, polivalente altamente inmunogénica contra mastitis en mamíferos
MX2017006892A MX2017006892A (es) 2014-11-28 2015-11-25 Vacuna subunitaria, polivalente altamente inmunogenica contra mastitis en mamiferos.
CONC2017/0005389A CO2017005389A2 (es) 2014-11-28 2017-05-26 Vacuna subunitaria, polivalente altamente inmunogénica contra mastitis en mamíferos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2014003247A CL2014003247A1 (es) 2014-11-28 2014-11-28 Vacuna subunitaria, polivalente contra mastitis en mamíferos, que comprende fragmentos de pared y membrana celular de patógenos seleccionados de staphylococcus aureus, escherichia coli y streptococcus uberis; procedimiento de preparación; y uso para inmunogenizar un mamífero.

Publications (1)

Publication Number Publication Date
CL2014003247A1 true CL2014003247A1 (es) 2015-07-10

Family

ID=56073267

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003247A CL2014003247A1 (es) 2014-11-28 2014-11-28 Vacuna subunitaria, polivalente contra mastitis en mamíferos, que comprende fragmentos de pared y membrana celular de patógenos seleccionados de staphylococcus aureus, escherichia coli y streptococcus uberis; procedimiento de preparación; y uso para inmunogenizar un mamífero.

Country Status (5)

Country Link
BR (1) BR112017011292B1 (es)
CL (1) CL2014003247A1 (es)
CO (1) CO2017005389A2 (es)
MX (1) MX2017006892A (es)
WO (1) WO2016082054A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024072985A1 (en) * 2022-09-28 2024-04-04 University Of Tennessee Research Foundation Polyvalent vaccines for staphylococcal & streptococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011018858A1 (ja) * 2009-08-14 2011-02-17 エヌエーアイ株式会社 新規乳房炎ワクチン

Also Published As

Publication number Publication date
BR112017011292B1 (pt) 2024-01-16
WO2016082054A9 (es) 2016-06-23
CO2017005389A2 (es) 2017-07-19
WO2016082054A1 (es) 2016-06-02
BR112017011292A2 (pt) 2017-12-26
MX2017006892A (es) 2018-01-23

Similar Documents

Publication Publication Date Title
IL285972B (en) Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
HUE054103T2 (hu) Izokinolin-3-il-karboxamidok, ezek elõállítása és alkalmazása
HUE053084T2 (hu) Streptococcus suis fertõzés elleni vakcinakészítmény
IL264454A (en) Novel compositions, uses and methods for making them
BR112016021626A2 (pt) indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas
HUE051862T2 (hu) Stabil, IFNAR1-elleni készítmény
EP3351540A4 (en) CYCLOHEXANDERIVATE OR STEREOISOMER OR SALT AND MANUFACTURE AND USE THEREOF
IL244697A0 (en) Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
EP3253368A4 (en) Cannabinoid and sugar alcohol complex, methods to make and use
BR112016011830A2 (pt) composições bacterianas sinergísticas e métodos para produção e uso das mesmas.
DK3137168T3 (da) Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse
EP3119424A4 (en) Immunogenic glycopeptides, composition comprising the glycopeptides and use thereof
GB2532302B (en) Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms.
HUE046033T2 (hu) Új kriptoficin vegyületek és konjugátumok, elõállításuk és gyógyászati alkalmazásuk
EP3273989C0 (en) STREPTOCOCCAL VACCINE
LT3169307T (lt) Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną
PL3232780T3 (pl) Kompozycje adiuwantowe zawierające wodny elektrolit, kompozycje zawierające składnik czynny i ich zastosowanie
EP3528839C0 (en) EXPEC GLYCOCONJUGATE VACCINE FORMULATIONS
DK3355933T3 (da) Adeninkonjugatforbindelser og deres anvendelse som vaccineadjuvanser
PL3794204T3 (pl) Asymetryczna, bezpieczna, próżniowo izolowana szyba zespolona
HUE063831T2 (hu) Eljárás aktivált õssejtek elõállítására, felhasználására és bejuttatására
IL265869A (en) Compound structures and their uses against staphylococcus infections
DK3344289T3 (da) Pestivirusvacciner mod medfødt tremor
HRP20180773T1 (hr) Otopine sildenafila, te postupci njihove priprave i upotrebe
CL2014003247A1 (es) Vacuna subunitaria, polivalente contra mastitis en mamíferos, que comprende fragmentos de pared y membrana celular de patógenos seleccionados de staphylococcus aureus, escherichia coli y streptococcus uberis; procedimiento de preparación; y uso para inmunogenizar un mamífero.